Sunday, May 19, 2024
HomeLatest NewsHealthCOVID-19: AstraZeneca vaccine to be withdrawn due to 'dangerous side effect'

COVID-19: AstraZeneca vaccine to be withdrawn due to ‘dangerous side effect’


Firm cites decreased demand resulting from availability of newer vaccines for its determination to withdraw “Vaxzevria”

Vials labelled “Astra Zeneca COVID-19  Vaccine” and a syringe are seen in entrance of a displayed AstraZeneca brand, on this illustration picture taken March 14, 2021. — Reuters
  • AstraZeneca has admitted its vaccine inflicting TTS, blood clots.
  • Firm’s Vaxzevria has been linked with not less than 81 deaths in UK.
  • Vaccine producer is being sued by 50 individuals for its unwanted side effects.

Famend pharmaceutical firm AstraZeneca has introduced the withdrawal of its COVID-19 vaccine Vaxzevria globally months after acknowledging vaccine’s “uncommon and harmful facet impact,” The Telegraph reported.

As per the publication, the mentioned vaccine has been below scrutiny over a facet impact that ends in blood clots and low blood platelet counts.

The event comes as the corporate, which has admitted to its vaccine inflicting Thrombosis with Thrombocytopenia Syndrome (TTS) on uncommon events, is going through authorized motion by 50 alleged victims and family of deceased people in a excessive courtroom for inflicting the aforesaid facet impact.

Thus far, not less than 81 deaths in UK have been related to the Vaxzevria vaccine.

Nevertheless, the corporate had cited “fall in demand” as the rationale behind its determination to withdraw the vaccine.

“As a number of, variant COVID-19 vaccines have since been developed there’s a surplus of obtainable up to date vaccines,” the corporate mentioned in an announcement on Tuesday.

The assertion additional underscored that the surplus inventory of newer vaccines has resulted in decreased demand for Vaxzevria, which is not being manufactured or provided.

Moreover, the producer may even be withdrawing Vaxzevria’s advertising and marketing authorisations inside Europe.

The agency’s software to withdraw the vaccine was made on March 5 and got here into impact on Could 7, in accordance with the Telegraph, which first reported the event.

London-listed AstraZeneca started shifting into respiratory syncytial virus vaccines and weight problems medication via a number of offers final yr after a slowdown in progress as COVID-19 medication gross sales declined.

In accordance with the corporate, as quoted by The Guardian, greater than 6.5 million lives had been saved within the first yr of use alone and over 3 billion doses had been provided globally.

AstraZeneca’s COVID-19 vaccine was additionally authorized to be used by the Pakistani authorities in its bid to curb the speedy unfold of the pandemic within the nation.

The mentioned vaccine includes of one other virus which is actually modified to have the gene for making a protein from coronavirus inflicting SARS-CoV-2. 

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments